BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8021724)

  • 1. Applicability of the International Index for aggressive lymphomas to patients with low-grade lymphoma.
    López-Guillermo A; Montserrat E; Bosch F; Terol MJ; Campo E; Rozman C
    J Clin Oncol; 1994 Jul; 12(7):1343-8. PubMed ID: 8021724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follicular large-cell lymphoma: intermediate or low grade?
    Bartlett NL; Rizeq M; Dorfman RF; Halpern J; Horning SJ
    J Clin Oncol; 1994 Jul; 12(7):1349-57. PubMed ID: 8021725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The International Prognostic Index can be used as a guide to treatment decisions regarding patients with human immunodeficiency virus-related systemic non-Hodgkin lymphoma.
    Rossi G; Donisi A; Casari S; Re A; Cadeo G; Carosi G
    Cancer; 1999 Dec; 86(11):2391-7. PubMed ID: 10590382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the International Prognostic Index for aggressive lymphomas useful for low-grade lymphoma patients? Applicability to stage III-IV patients. The GOELAMS Group, France.
    Foussard C; Desablens B; Sensebe L; François S; Milpied N; Deconinck E; Delwail V; Dugay J; Lamy T; Ghandour C; Le Mevel A; Maisonneuve H; Casassus P; Colombat P
    Ann Oncol; 1997; 8 Suppl 1():49-52. PubMed ID: 9187429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CEOP-B alternated with VIMB in intermediate-grade and high-grade non-Hodgkin's lymphoma: a pilot study.
    De Lena M; Ditonno P; Lorusso V; Brandi M; Timurian A; Marzullo F; Ventrella V; Pellecchia A
    J Clin Oncol; 1995 Apr; 13(4):953-60. PubMed ID: 7535844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of treatment on the prognostic value of S-phase fraction in non-Hodgkin's lymphoma.
    Joensuu H; Ristamäki R; Söderström KO; Jalkanen S
    J Clin Oncol; 1994 Oct; 12(10):2167-75. PubMed ID: 7931487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Non-Hodgkin's lymphomas. II. Analysis of the prognostic factors in a series of 307 patients].
    García Zueco JC; Delgado MP; Giraldo MP; Perella M; Rubio-Félix D; Giralt M
    Sangre (Barc); 1992 Oct; 37(5):337-44. PubMed ID: 1293772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in aggressive malignant lymphomas: description and validation of a prognostic index that could identify patients requiring a more intensive therapy. The Groupe d'Etudes des Lymphomes Agressifs.
    Coiffier B; Gisselbrecht C; Vose JM; Tilly H; Herbrecht R; Bosly A; Armitage JO
    J Clin Oncol; 1991 Feb; 9(2):211-9. PubMed ID: 1703226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presenting features, natural history, and prognostic factors in localized non-Hodgkin's lymphomas: analysis of 117 cases from a single institution.
    Esteve J; López-Guillermo A; Martínez-Francés A; Bosch F; Terol MJ; Campo E; Montserrat E; Rozman C
    Eur J Haematol; 1995 Oct; 55(4):217-22. PubMed ID: 7589337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Post-therapeutic evolution and prognostic factors of intestinal lymphomas, Retrospective analysis of 42 cases].
    Sánchez-Fayos MP; Hernández Guío C; Rivas MC; Outeiriño J; González-Campos C; Lobo F
    Sangre (Barc); 1993 Dec; 38(6):455-62. PubMed ID: 8171381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of the Follicular Lymphoma International Prognostic Index score in marginal zone lymphoma: an analysis of clinical presentation and outcome in 144 patients.
    Heilgeist A; McClanahan F; Ho AD; Witzens-Harig M
    Cancer; 2013 Jan; 119(1):99-106. PubMed ID: 22736411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Primary extralymphatic non-Hodgkin's lymphomas: the response to treatment and prognostic factors in 73 patients].
    Oriol A; Ribera JM; Flores A; Batlle M; las Heras G; Vaquero M; Juncá J; Millá F; Feliu E
    Med Clin (Barc); 1995 Mar; 104(8):281-6. PubMed ID: 7700086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the adhesion molecule ICAM-1 in non-Hodgkin's lymphoma: relationship with tumor dissemination and prognostic importance.
    Terol MJ; López-Guillermo A; Bosch F; Villamor N; Cid MC; Rozman C; Campo E; Montserrat E
    J Clin Oncol; 1998 Jan; 16(1):35-40. PubMed ID: 9440720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-Hodgkin's lymphoma in Pakistan: a clinicopathological profile of 175 patients.
    Aziz Z; Rehman A; Akram M; Saeed A
    J Pak Med Assoc; 1999 Jan; 49(1):11-5. PubMed ID: 10463009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic factors in low-grade lymphoma].
    Gandarillas MA; Conde E; Mazorra F; Cuadrado MA; Baro J; Garijo J; Recio M; Richard C; Iriondo A; Zubizarreta A
    Sangre (Barc); 1998 Jun; 43(3):185-90. PubMed ID: 9741223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applicability of international prognostic index in non Hodgkin's lymphoma in Pakistan.
    Aziz Z; Sana S; Saeed S; Akram M
    J Ayub Med Coll Abbottabad; 2004; 16(2):15-20. PubMed ID: 15455610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follicular lymphoma in early stages: high risk of relapse and usefulness of the Follicular Lymphoma International Prognostic Index to predict the outcome of patients.
    Plancarte F; López-Guillermo A; Arenillas L; Montoto S; Giné E; Muntañola A; Ferrer A; Villamor N; Bosch F; Colomo L; Balaguer O; Campo E; Montserrat E
    Eur J Haematol; 2006 Jan; 76(1):58-63. PubMed ID: 16343272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. International and Italian prognostic indices in follicular lymphoma.
    Perea G; Altés A; Montoto S; López-Guillermo A; Bosch F; Jiménez M; Esteve J; Domingo E; Ribera JM; Pedro C; Martino R; Briones J; Sureda A; Brunet S; Sierra J; Montserrat E
    Haematologica; 2003 Jun; 88(6):700-4. PubMed ID: 12801847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment outcome and prognostic factors for relapse after high-dose chemotherapy and peripheral blood stem cell rescue for patients with poor risk high grade non-Hodgkin's lymphoma.
    Lee SM; Ryder WD; Clemons MJ; Morgenstern GR; Chang J; Scarffe JH; Radford JA
    Bone Marrow Transplant; 1999 Aug; 24(3):271-7. PubMed ID: 10455365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.